| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 18, 2006
Accepted on April 11, 2007
Cardiovascular Research Institute Maastricht (CARIM). Department of Internal Medicine, Laboratory of Molecular Metabolism and Endocrinology, University of Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (CARIM). Department of Population Genetics, Genomics and Bio-informatics, University of Maastricht, the Netherlands; Department of Human Genetics, University of Leuven, Belgium; Cardiovascular Research Institute Maastricht (CARIM). Department of Molecular Genetics, University of Maastricht, the Netherlands; Department of Pathology and Laboratory Medicine, University Medical Center Groningen and University of Groningen, the Netherlands; Division of Human Nutrition, Section Nutrion and Epidemiology, Wageningen University, the Netherlands; Centre for Nutrition and Health, National Institute for Public Health and the Environment, Bilthoven, The Netherlands; GlaxoSmithKline, Translational Medicine & Genetics 5.5622, North Carolina 27709, USA
* To whom correspondence should be addressed. E-mail: steven.meex{at}intmed.unimaas.nl.
Context: Activating Transcription Factor 6 (ATF6) is critical for initiation and full activation of the unfolded protein response. An association between genetic variation in ATF6 and type 2 diabetes was recently reported in Pima Indians.
Objective: To investigate the broader significance of this association for type 2 diabetes, replication studies in distinct ethic populations are required. We investigated ATF6 for its association with type 2 diabetes in Dutch Caucasians.
Design: Genetic association study
Setting: Academic research laboratory
Study participants: Two independent Dutch cohorts. Cohort 1 (N=154) was used to evaluate genetic variation in the ATF6-gene in relation to glucose homeostasis in the general population. Cohort 2 (N=798) consisted of patients with type 2 diabetes, impaired glucose tolerance, impaired fasting glucose, and normoglycaemic control subjects and was used to investigate ATF6 polymorphisms for their contribution to disturbed glucose homeostasis and type 2 diabetes.
Main outcome measures: Sixteen tag-SNPs were genotyped in all subjects of both cohorts. Those SNPs included three nonsynonymous coding variants and captured all common allelic variation of ATF6.
Results: Our data show that common ATF6 variants are associated with elevated glucose levels in the general population (Cohort 1, P=0.005-0.05). Furthermore, the majority of these variants, and haplotypes thereof, were significantly associated with impaired fasting glucose, impaired glucose tolerance and type 2 diabetes. (Cohort 2, p=0.006-0.05). Associated variants differ from those identified in Pima Indians.
Conclusions: Our results strengthen the evidence that one or more variants in ATF6 are associated with disturbed glucose homeostasis and type 2 diabetes.
This article has been cited by other articles:
![]() |
D. Scheuner and R. J. Kaufman The Unfolded Protein Response: A Pathway That Links Insulin Demand with {beta}-Cell Failure and Diabetes Endocr. Rev., May 1, 2008; 29(3): 317 - 333. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |